Executive summary

22 patients with T1 to T2 N0M0 NSCLC received image-guided hypofractionated PBT to a total dose 48 GyRBE in 4 fractions for peripheral lesions and 60 GyRBE in 10 fractions for central lesions. The overall survival rates at 3 and 5 years were 81% and 49%. One patient (5%) developed a late grade 3 bronchial stricture requiring hospitalization and stent. 

Top cancer treatments